Search

Your search keyword '"Aly, Markus"' showing total 435 results

Search Constraints

Start Over You searched for: Author "Aly, Markus" Remove constraint Author: "Aly, Markus"
435 results on '"Aly, Markus"'

Search Results

1. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

6. Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years’ Report from the EAU Robotic Urology Section Scientific Working Group

8. The effect of sample size on polygenic hazard models for prostate cancer

9. A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data

12. Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists.

14. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

15. Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.

16. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

17. Prostate Cancer Incidence and Mortality in Men Exposed to α1-Adrenoceptor Antagonists

18. MP14-02 IDENTIFY THE OPTIMAL CANDIDATES FOR ADJUVANT ANDROGEN DEPRIVATION THERAPY AMONG PATIENTS WITH DETECTABLE PSA AFTER RADICAL PROSTATECTOMY

19. PD29-12 THE IMPACT OF THE TIME ELAPSED BETWEEN PRIMARY TREATMENT AND BCR ON CANCER SPECIFIC MORTALITY IN PATIENTS WHO EXPERIENCED BCR AFTER PRIMARY TREATMENT

20. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial

21. Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study

23. Risk of Venous Thromboembolic Events After Surgery for Cancer

24. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

25. Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation.

26. Risk of Postoperative Ischemic Stroke and Myocardial Infarction in Patients Operated for Cancer

27. Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years’ Report from the EAU Robotic Urology Section Scientific Working Group

38. Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer

39. Supplementary Methods, Figures S1 - S3 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

40. Supplementary Tables S1 - S10 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

41. Supplementary Acknowledgments from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

42. Data from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

43. Supplementary Grant Support from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

44. PD38-11 THE STOCKHOLM3 PROSTATE CANCER SCREENING TRIAL (STHLM3): AN INTERIM ANALYSIS OF MORTALITY RESULTS AFTER 6.5 YEARS OF FOLLOW-UP

45. PD15-04 PREDICTION OF PROSTATE CANCER SPECIFIC MORTALITY IN MEN UNDERGOING RADIOTHERAPY WITH OR WITHOUT HORMONAL TREATMENT, RISK STRATIFICATION BASED ON CLINICAL CHARACTERISTICS AND PSA TREATMENT RESPONSE

46. MP17-06 VALIDATION OF EAU RISK GROUPS FOR BIOCHEMICAL RECURRENCE AFTER RADIOTHERAPY AND RADICAL PROSTATECTOMY FOR PREDICTION OF PROSTATE CANCER MORTALITY

47. Supplementary notes from Genome-Wide Association Study of Prostate Cancer–Specific Survival

48. Data from Genome-Wide Association Study of Prostate Cancer–Specific Survival

49. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

Catalog

Books, media, physical & digital resources